Hypertension Circulatory System Essential (primary) hypertension
Conditions
Interventions
From the population of Figueres city a sample population of 48 individuals will be extracted, by simple random sampling, these will be randomized into two groups A and B:
A. OLE, mark
Sponsors
Institut Universitari d'Investigació en Atenció primària Jordi Gol i Gorina (IdIAP)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Men and women aged 25-65 2. Diagnosed with essential hypertension grade 1 3. Without allergy to the components of the leaf extract of the olive or the capsule 4. Low CV risk 5. Who don't take hypertension treatment a month before inclusion 6. Do not have a target organ lesion and/or chronic illnesses (kidney, respiratory, cardiac, liver, haematological, infectious, etc) according to the European Guide for the management of the HTA ESH ESC 2013 7. Informed consent
Exclusion criteria
Exclusion criteria: 1. People with HTA grade 2 and 3 2. Grade 1 with a moderate CV risk, or high or very high according to the ESH-ESC 2013 Guidelines 3. With LOD or with subclinical vascular disease 4. With cognitive or idiomatic difficulty in fulfilling the instructions 5. Having chronic illnesses 6. Taking treatments that interfere or contraindicate the administration of the components of the olive leaf 7. Lactose intolerance 8. Pregnancy or breastfeeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ambulatory blood pressure (in mmHg) measured at the beginning and end of each treatment period (placebo or active treatment) | — |
Secondary
| Measure | Time frame |
|---|---|
| Hypertension control (BP < 140/90 mmHg; in percentage) measured at the beginning and end of each treatment period (placebo or active treatment) | — |
Countries
Spain
Outcome results
None listed